Avanos Medical (AVNS) Capital Expenditures Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 2.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.44% |
| Dec 31, 2025 | -30.06% |
| Sep 30, 2025 | 9.72% |
| Jun 30, 2025 | 38.95% |
| Mar 31, 2025 | 10.25% |
| Dec 31, 2024 | 11.57% |
| Sep 30, 2024 | -14.50% |
| Jun 30, 2024 | 0.57% |
| Mar 31, 2024 | -10.40% |
| Dec 31, 2023 | 35.80% |
| Sep 30, 2023 | 9.14% |
| Jun 30, 2023 | -16.62% |
| Mar 31, 2023 | -8.37% |
| Dec 31, 2022 | -48.82% |
| Sep 30, 2022 | -9.29% |
| Jun 30, 2022 | -43.64% |
| Mar 31, 2022 | -26.32% |
| Dec 31, 2021 | -37.59% |
| Sep 30, 2021 | -23.45% |
| Jun 30, 2021 | -19.46% |
| Mar 31, 2021 | -15.95% |
| Dec 31, 2020 | 23.47% |
| Sep 30, 2020 | -40.16% |
| Jun 30, 2020 | 2.54% |
| Mar 31, 2020 | -20.11% |
| Dec 31, 2019 | 35.89% |
| Sep 30, 2019 | -2.24% |
| Jun 30, 2019 | 55.42% |
| Mar 31, 2019 | 16.04% |
| Dec 31, 2018 | 32.02% |
| Sep 30, 2018 | -17.71% |
| Jun 30, 2018 | -14.08% |
| Mar 31, 2018 | -29.76% |
| Dec 31, 2017 | 12.46% |
| Sep 30, 2017 | -24.40% |
| Jun 30, 2017 | -32.16% |
| Mar 31, 2017 | 10.79% |
| Dec 31, 2016 | 25.14% |